Scorpio Gold Corp. {TSX.V: SGN} announces the resignation of Peter J. Hawley from the position of President, effective immediately, for personal reasons.
Mr. Hawley has indicated that he will also retire from the position of CEO of the Company on October 31, 2016, or at such time as a replacement is found. He intends to remain as Chairman and a director of the Company. Continue reading
Inovio Pharmaceuticals, Inc. {NASDAQ: INO} reported financial results for the quarter ended June 30, 2016.
The following financial results provide a year-over-year comparison of the second quarter in 2016 and 2015. Total revenue was $6.2 million compared to $5.3 million. Continue reading
Minera IRL Ltd. {BVL: MIRL} announced the resumption of drilling at the Ollachea flagship gold project in Puno, Southern Peru.
The program contemplates 5,230 mts of diamond drilling consisting of 23 holes drilled
from 6 platforms from within the Ollachea tunnel. Continue reading
Barkerville Gold Mines Ltd. {TSXV: BGM} announced results from the ongoing Phase I exploration and category conversion drilling program on Cow Mountain at the Company’s flagship Cariboo Gold Project. Continue reading
Inovio Pharmaceuticals, Inc. {NASDAQ: INO} announced the appointment of Dr. Ami Shah Brown as Vice President Regulatory Affairs.
Dr. Brown, who joined Inovio in 2011 as Senior Director of Regulatory Affairs, will be responsible for developing and implementing Inovio’s regulatory strategies. Continue reading
Nymox Pharmaceutical Corp. {NASDAQ: NYMX} Director James George Robinson purchased 22,500 shares of the company’s stock in a transaction dated Friday, July 29th.
The stock was purchased at an average price of $3.86 per share, for a total transaction of $86,850.00. Continue reading
Scorpio Gold Corp. {TSX.V: SGN} reports its intention to undertake Phase 2 of an exploration program on its Nevada Assets totalling approximately US$750,000.
This will include work at Mineral Ridge and Goldwedge. Continue reading
Inovio Pharmaceuticals, {NASDAQ: INO} today announced the company will continue to develop its hepatitis B DNA immunotherapy (INO-1800) independently following Roche’s notice that it will discontinue its collaboration with Inovio and its development of INO-1800. Continue reading
Cartier Resources Inc.{TSX.V: ECR} has provided its first results on the Wilson property, situated 15 kilometres east of Lebel-sur-Quevillon.
Channel sampling discovered several high grade values. Continue reading
Neometals {ASX: NMT} are presenting at the annual Diggers and Dealers Conference in Kalgoorlie, Western Australia.
A copy of their presentation for this event is available to download. Continue reading
